Sakhaee K, Alpern R, Jacobson H R, Pak C Y
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.
J Clin Endocrinol Metab. 1991 Feb;72(2):396-400. doi: 10.1210/jcem-72-2-396.
Mechanisms for the citraturic response to potassium citrate treatment were sought by assessing renal citrate clearance and acid-base status after oral administration of potassium citrate, potassium bicarbonate, and potassium chloride. After 2 weeks of treatment of eight patients with stones at a dose of 80 meq/day, urinary citrate rose significantly from 2.5 +/- 1.6 mmol/day (no drug) to 5.1 +/- 1.7 mmol/day with potassium citrate and to 4.5 +/- 1.5 mmol/day with potassium bicarbonate (P less than 0.05), but did not change significantly with potassium chloride. Citrate clearance increased from 8.0 to 27.4 mL/min with potassium citrate and 25.8 mL/min with potassium bicarbonate (P less than 0.05), but did not increase with potassium chloride. Both potassium citrate and potassium bicarbonate significantly raised urinary bicarbonate and decreased urinary ammonium, titratable acid, and net acid excretion. Potassium chloride was without effect. Effects of potassium citrate on urinary citrate, citrate clearance, and acid-base status tended to be more prominent than those of potassium bicarbonate, but these changes were not significant. Thus, the citraturic action of potassium citrate is largely accountable for by provision of an alkali load. Potassium itself had no effect in the absence of potassium deficiency.
通过评估口服柠檬酸钾、碳酸氢钾和氯化钾后肾脏柠檬酸盐清除率及酸碱状态,探寻柠檬酸钾治疗导致尿枸橼酸盐反应的机制。以每日80毫当量的剂量对8例结石患者进行2周治疗后,尿枸橼酸盐显著升高,从无药物时的2.5±1.6毫摩尔/天,升至服用柠檬酸钾时的5.1±1.7毫摩尔/天,服用碳酸氢钾时为4.5±1.5毫摩尔/天(P<0.05),但服用氯化钾时无显著变化。服用柠檬酸钾时,柠檬酸盐清除率从8.0升至27.4毫升/分钟,服用碳酸氢钾时为25.8毫升/分钟(P<0.05),但服用氯化钾时未升高。柠檬酸钾和碳酸氢钾均显著提高尿碳酸氢盐水平,并降低尿铵、可滴定酸和净酸排泄。氯化钾无此作用。柠檬酸钾对尿枸橼酸盐、枸橼酸盐清除率及酸碱状态的影响往往比碳酸氢钾更显著,但这些变化并不显著。因此,柠檬酸钾的促尿枸橼酸盐作用很大程度上是由于提供了碱负荷。在无钾缺乏的情况下,钾本身无作用。